Affiliated institution
Program DirectorNational Institutes of Health

Dr. Andrew Weitz joined the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIHthe primary U.S. federal agency supporting biomedical and public health research as a Program Director in 2017. He supports a variety of trans-NIH and trans-agency initiatives, with a focus on health informatics, digital health, and open science.

Dr. Weitz leads digital health strategy for the Rapid Acceleration of Diagnostics (RADx®) Tech program, which received more than $1.5B from Congress to speed the development and commercialization of point-of-care and home-based diagnostic tests. In this role, Dr. Weitz established the RADx MARS program and MakeMyTestCount.org, which facilitate standardized test result reporting from over-the-counter diagnostics. He has also held leadership roles in other NIH initiatives including Home Test to Treat, REsearching COVID to Enhance Recovery (RECOVER), and Say Yes! COVID Test. In addition, Dr. Weitz is part of the leadership team for Stimulating Peripheral Activity to Relieve Conditions (SPARC), a program focused on electrical stimulationthe use of controlled electric current to activate or alter neural activity of peripheral nerves for treating various diseases and conditions.

Prior to joining NIH, Dr. Weitz was as a Research Assistant Professor at the University of Southern California Institute for Biomedical Therapeutics, where he investigated novel neuromodulation approaches for treating blindnesssevere vision loss that may still include some remaining sight.

Experience

Education

Article information

Not yet verified. This page has not been verified by an expert yet, so the information presented here may be incomplete or inaccurate.

Last updated October 04, 2023 at 4:01 AM.

The following people contributed to this page:

Report an issue